Fibricor (U.S. Rights) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Fibricor (U.S. Rights) General Information
Description
The distribution and production rights of a therapy drug. The drug is used as adjunctive therapy to diet for treatment of severe hyperglycemia and as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol.
Contact Information
Corporate Office
- 1 Commerce Drive
- Cranbury, NJ 08512
- United States
Corporate Office
- 1 Commerce Drive
- Cranbury, NJ 08512
- United States
Fibricor (U.S. Rights) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Fibricor (U.S. Rights) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Fibricor (U.S. Rights) FAQs
-
Where is Fibricor (U.S. Rights) headquartered?
Fibricor (U.S. Rights) is headquartered in Cranbury, NJ.
-
What industry is Fibricor (U.S. Rights) in?
Fibricor (U.S. Rights)’s primary industry is Buildings and Property.
-
Is Fibricor (U.S. Rights) a private or public company?
Fibricor (U.S. Rights) is a Private company.
-
What is the current valuation of Fibricor (U.S. Rights)?
The current valuation of Fibricor (U.S. Rights) is .
-
What is Fibricor (U.S. Rights)’s current revenue?
The current revenue for Fibricor (U.S. Rights) is .
-
Who are Fibricor (U.S. Rights)’s investors?
Sun Pharmaceutical Industries has invested in Fibricor (U.S. Rights).
-
When was Fibricor (U.S. Rights) acquired?
Fibricor (U.S. Rights) was acquired on 21-May-2015.
-
Who acquired Fibricor (U.S. Rights)?
Fibricor (U.S. Rights) was acquired by Tribute Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process